N-Acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 26-31

  Wang, Zheng ^a,b   Zheng, Lanhong ^a   Yang, Shaoli ^a   Niu, Rongli ^a   Chu, Edward ^c   Lin, Xiukun ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c YALE CANCER CENTER   (United States)

Author keywords

Antiangiogenesis; Chitooligosaccharide; Human umbilical vein endothelial cells; N Acetylchitooligosaccharide; Zebrafish

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITOR; CHITOSE OLIGOSACCHARIDE; N ACETYLCHITOOLIGOSACCHARIDE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACETYLATION; EMBRYO; ENDOTHELIUM CELL; ENZYME ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN; ZEBRA FISH;

ANGIOGENESIS INHIBITORS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NIH 3T3 CELLS; OLIGOSACCHARIDES; ZEBRAFISH;

DANIO RERIO;

EID: 34147138790     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.094     Document Type: Article

References (31)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J. Natl. Cancer Inst. 82 (1990) 4-6
2. Ellis L.M., Liu W., Ahmad S.A., Fan F., Jung Y.D., Shaheen R.M., and Reinmuth N. Overview of angiogenesis: biologic implications for antiangiogenetic therapy. Semin. Oncol. 28 (2001) 94-104
3. Jubb A.M., Oates A.J., Holden S., and Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat. Rev. Cancer 6 (2006) 626-635
4. Kerbel R.S. Tumor angiogenesis, past, present and the near future. Carcinogenesis 21 (2000) 505-515
5. Muzzarelli R.A.A. Chitin (1977), Oxford Pergamon Press, London
6. Suzuki K., Mikami T., Okawa Y., Tokoro A., Suzuki S., and Suzuki M. Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydr. Res. 151 (1986) 403-408
7. Qin C.Q., Du Y.M., Xiao L., Li Z., and Gao X.H. Enzymic preparation of water-soluble chitosan and their antitumor activity. Int. J. Biol. Macromol. 31 (2002) 111-117
8. Feng J., Zhao L., and Yu Q. Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem. Biophys. Res. Commun. 317 (2004) 414-420
9. Maeda Y., and Kimura Y. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J. Nutr. 134 (2004) 945-950
10. Huang R., Mendis E., Rajapakse N., and Kim S.K. Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sci. 78 (2006) 2399-2408
11. Lee J.K., Lim H.S., and Kim J.H. Cytotoxic activity of aminoderivatized cationic chitosan derivatives. Bioorg. Med. Chem. Lett. 12 (2002) 2949-2951
12. Pae H.O., Seo W.G., Kim N.Y., Oh G.S., Kim G.E., Kim Y.H., Kwak H.J., Yun Y.G., Jun C.D., and Chung H.T. Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer. Leuk. Res. 25 (2001) 339-346
13. Harish Prashanth K.V., and Tharanathan R.N. Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis. Biochim. Biophys. Acta 1722 (2005) 22-29
14. Sun Y., Liu W., Han B., Zhang J., and Liu B. Purification and characterization of two types of chitosanase from a Microbacterium sp. Biotechnol. Lett. 28 (2006) 1393-1399
15. Aiba S. Preparation of N-acetylchitooligosaccharides by hydrolysis of chitosan with chitinase followed by N-acetylation. Carbohydr. Res. 265 (1994) 323-328
16. Imoto T., and Yagishita K. A simple activity measurement of lysozyme. Agric. Biol. Chem. 35 (1971) 1154-1156
17. Domard A. Determination of N-acetyl content in chitosan samples by c.d. measurements. Int. J. Biol. Macromol. 9 (1987) 333-336
18. Marin V., Kaplanski G., Gres S., Farnarier C., and Bongrand P. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods. 254 (2001) 183-190
19. He Q.J., Yang B., Lou Y.J., and Fang R.Y. Contragestazol (DL111-IT) inhibits proliferation of human androgen-independent prostate cancer cell line PC3 in vitro and in vivo. Asian J. Androl. 7 (2005) 389-393
20. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26 (1967) 365-369
21. Grimsley C.M., Kinchen J.M., Tosello-Trampont A.C., Brugnera E., Haney L.B., Lu M.J., Chen Q., Klingele D., Hengartner M.O., and Ravichandran K.S. Dock180 and ELM01 proteins cooperate evolutionarily conserved Rac-dependent cell migration. J. Biol. Chem. 279 (2004) 6087-6097
22. Funahashi Y., Sugi N.H., Semba T., Yamamoto Y., Hamaoka S., Tsukahara-Tamai N., Ozawa Y., Tsuruoka A., Nara K., Takahashi K., Okabe T., Kamata J., Owa T., Ueda N., Haneda T., Yonaga M., Yoshimatsu K., Wakabayashi T., Ausprunk D.H., and Folkman J. Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium. Cancer Res. 62 (2002) 6116-6123
23. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio). fourth ed. (2000), University of Oregon Press, Eugene
24. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., and Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203 (1995) 253-310
25. Fouquet B., Weinstein B.M., Serluca F.C., and Fishman M.C. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev. Biol. 183 (1997) 37-48
26. Serbedzija G.N., Flynn E., and Willett C.E. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis 3 (1999) 353-359
27. Parng C., Seng W.L., Semino C., and McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev. Technol. 1 (2002) 41-48
28. Shiu Y.T., Weiss J.A., Hoying J.B., Iwamoto M.N., Joung I.S., and Quam C.T. The role of mechanical stresses in angiogenesis. Crit. Rev. Biomed. Eng. 33 (2005) 431-510
29. Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., and Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science. 223 (1984) 1296-1299
30. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., and Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219 (1983) 983-985
31. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., and Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-845